Portfolio company
Acacia Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops and commercialises hospital pharmaceutical products for patients undergoing surgery, invasive procedures or cancer chemotherapy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Acrux
This company develops and commercialises topical pharmaceutical products for patients and global licensing partners.
Paion
This pharmaceutical company develops and distributes sedative and anaesthetic medicines for hospitals and intensive care clinics.
Phaxiam
The company develops bacteriophage-based treatments to combat antibiotic-resistant bacterial infections for patients with severe hospital-acquired or chronic respiratory conditions.
ADVANZ PHARMA
This pharmaceutical company develops and supplies specialty, hospital and rare disease medicines to healthcare systems and patients globally.
Speciality European Pharma
This company develops and distributes pharmaceutical products and medical devices for urological and gynaecological conditions to specialist physicians and hospitals across Europe.
Intercept Pharmaceuticals
This company develops and commercialises small molecule therapeutics to treat chronic liver diseases for healthcare providers and patients.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
Acesion Pharma
The company develops ion channel inhibitors to treat atrial fibrillation for patients with cardiac arrhythmia.